Susan Gutierrez

Mar 8, 2024 | mondaq.com | Bart O. Williams |Susan Gutierrez |William D Dalsen |Om V. Alladi

The allegation sounded serious: defendant Gilead Sciences was accused of having struck an anticompetitive pay-for-delay patent deal with a generic manu­facturer that harmed people with HIV. The plaintiffs sought $3.6 billion. But lawyers from Proskauer Rose LLP, Kirkland & Ellis LLP and Goodwin Procter LLP — making up a trial team led by Proskauer's Bart H.